Mannschreck Diana, Matsuno Rayna K, Moriarty James P, Borah Bijan J, Dowdy Sean C, Tanner Edward J, Makary Martin A, Stone Rebecca L, Levinson Kimberly L, Temkin Sarah M, Fader Amanda N
Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, and the Department of Surgery, Johns Hopkins Medicine, Baltimore, Maryland; the Department of Radiation Medicine and Applied Sciences, University of California San Diego Health Sciences, La Jolla, California; and the Division of Health Care Policy & Research and the Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota.
Obstet Gynecol. 2016 Sep;128(3):526-34. doi: 10.1097/AOG.0000000000001567.
To analyze contemporary U.S. use of minimally invasive surgery for the treatment of endometrial cancer and associated inpatient complications and costs.
In this retrospective cohort study, the National Inpatient Sample database was analyzed in patients with nonmetastatic endometrial cancer who underwent hysterectomy during 2012-2013. Hierarchical multiple logistic regression and propensity score matching were used to compare complications among patients treated with open compared with minimally invasive hysterectomy surgery. Cost of care was also compared using generalized linear modeling.
We identified 9,799 patients; 52.4% underwent open and 47.6% minimally invasive hysterectomy. Many patients (43.4%) were treated at low-volume hospitals (less than 10 endometrial cancer cases annually). Patients were less likely to undergo open surgery in high-volume compared with low-volume hospitals (51.8% compared with 58.1%, respectively; adjusted odds ratio [OR] 0.35, 95% confidence interval [CI] 0.13-0.94) and more likely to undergo open surgery in rural compared with urban teaching hospitals (75.6% compared with 51.1%, respectively; adjusted OR 14.34, 95% CI 9.66-21.27), government compared with nonprofit hospitals (61.3% compared with 51.1%, respectively; adjusted OR 1.66, 95% CI 1.15-2.39), and in patients of black (67.9%; OR 1.46, 95% CI 1.30-1.65) and "other" race (60.5%; adjusted OR 2.39, 95% CI 1.99-2.87) compared with white race (49.2%, referent). Open surgery was associated with increased perioperative complications (adjusted OR 2.80, 95% CI 2.48-3.17) and a $1,243 increase in cost per case compared with minimally invasive approaches (P<.001). Using minimally invasive surgery for 80% of study patients may have averted 2,733 complications and saved approximately $19 million.
Most U.S. women with endometrial cancer continue to be treated with open hysterectomy surgery despite increased complication rates and financial costs associated with this approach. A disparity in endometrial cancer surgical care exists that is affected by patient race and hospital geography and cancer volumes.
分析当代美国使用微创手术治疗子宫内膜癌及其相关住院并发症和费用情况。
在这项回顾性队列研究中,对2012 - 2013年期间接受子宫切除术的非转移性子宫内膜癌患者的国家住院样本数据库进行分析。采用分层多元逻辑回归和倾向得分匹配法,比较接受开放性子宫切除术与微创子宫切除术患者的并发症情况。还使用广义线性模型比较护理费用。
我们共纳入9799例患者;52.4%接受开放性手术,47.6%接受微创子宫切除术。许多患者(43.4%)在低容量医院接受治疗(每年子宫内膜癌病例少于10例)。与低容量医院相比,高容量医院的患者接受开放性手术的可能性较小(分别为51.8%和58.1%;调整后的优势比[OR]为0.35,95%置信区间[CI]为0.13 - 0.94);与城市教学医院相比,农村医院的患者接受开放性手术的可能性更大(分别为75.6%和51.1%;调整后的OR为14.34,95% CI为9.66 - 21.27);与非营利性医院相比,政府医院的患者接受开放性手术的可能性更大(分别为61.3%和51.1%;调整后的OR为1.66,95% CI为1.15 - 2.39);与白人种族患者(49.2%,作为对照)相比,黑人(67.9%;OR为1.46,95% CI为1.30 - 1.65)和“其他”种族患者(60.5%;调整后的OR为2.39,95% CI为1.99 - 2.87)接受开放性手术的可能性更大。与微创方法相比,开放性手术与围手术期并发症增加相关(调整后的OR为2.80,95% CI为2.48 - 3.17),且每例成本增加1243美元(P <.001)。若80%的研究患者使用微创手术,可能避免2733例并发症,并节省约1900万美元。
尽管开放性子宫切除术存在较高的并发症发生率和经济成本,但大多数美国子宫内膜癌女性患者仍继续接受该手术治疗。子宫内膜癌手术治疗存在差异,受患者种族、医院地理位置和癌症病例数影响。